Medincell Sa Stock Current Valuation
| MEDCL Stock | EUR 16.30 1.28 8.52% |
Valuation analysis of Medincell SA helps investors to measure Medincell's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Medincell's price fluctuation is not too volatile at this time. Calculation of the real value of Medincell SA is based on 3 months time horizon. Increasing Medincell's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Medincell's intrinsic value may or may not be the same as its current market price of 16.30, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 16.3 | Real 14.82 | Hype 16.3 | Naive 15.76 |
The intrinsic value of Medincell's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Medincell's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Medincell SA helps investors to forecast how Medincell stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Medincell more accurately as focusing exclusively on Medincell's fundamentals will not take into account other important factors: Medincell SA Company Current Valuation Analysis
Medincell's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Medincell Current Valuation | 180.29 M |
Most of Medincell's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medincell SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Medincell SA has a Current Valuation of 180.29 M. This is 98.74% lower than that of the Healthcare sector and 96.12% lower than that of the Biotechnology industry. The current valuation for all France stocks is 98.92% higher than that of the company.
Medincell Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medincell's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medincell could also be used in its relative valuation, which is a method of valuing Medincell by comparing valuation metrics of similar companies.Medincell is currently under evaluation in current valuation category among its peers.
Medincell Fundamentals
| Return On Asset | -0.4 | |||
| Operating Margin | (3.25) % | |||
| Current Valuation | 180.29 M | |||
| Shares Outstanding | 25.22 M | |||
| Shares Owned By Insiders | 47.40 % | |||
| Shares Owned By Institutions | 18.95 % | |||
| Price To Book | 27.59 X | |||
| Price To Sales | 20.97 X | |||
| Revenue | 4.09 M | |||
| Gross Profit | 4.09 M | |||
| EBITDA | (21.45 M) | |||
| Net Income | (24.81 M) | |||
| Cash And Equivalents | 5 M | |||
| Cash Per Share | 1.24 X | |||
| Total Debt | 16.25 M | |||
| Debt To Equity | 4.61 % | |||
| Current Ratio | 4.14 X | |||
| Book Value Per Share | (1.04) X | |||
| Cash Flow From Operations | (21.36 M) | |||
| Earnings Per Share | (1.12) X | |||
| Target Price | 14.0 | |||
| Number Of Employees | 151 | |||
| Beta | 1.02 | |||
| Market Capitalization | 215.89 M | |||
| Total Asset | 44.3 M | |||
| Z Score | 7.8 | |||
| Net Asset | 44.3 M |
About Medincell Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medincell SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medincell using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medincell SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Medincell Stock Analysis
When running Medincell's price analysis, check to measure Medincell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medincell is operating at the current time. Most of Medincell's value examination focuses on studying past and present price action to predict the probability of Medincell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medincell's price. Additionally, you may evaluate how the addition of Medincell to your portfolios can decrease your overall portfolio volatility.